EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Rutin ameliorates hepatic ischemia-reperfusion injury by targeting CD36 to suppress hepatocyte ferroptosis

Zhenlong Liu, Miaomiao Wang, Liangyun Li, Wenmei Zhang, Wenna Meng, Chengjiang Cao, Hehang Song, Xue Fang, Yan Zhu, Ming Yang, Changlin Du, Yuan Zhang und 3 weitere

International Immunopharmacology · 2026-03 · 172 · 116231

DOI: 10.1016/j.intimp.2026.116231 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Immunopharmacology, 2026-03. Verfasst von Zhenlong Liu und 14 weiteren Autor:innen. Beteiligte Einrichtung: Inflammation and Immune Mediated Diseases Laboratory of Anhui Province, Anhui Institute of Innovative Drugs, School of Pharmacy, Anhui Medical Univer…. Hauptthemen laut MEDLINE: CD36 Antigens, Reperfusion Injury, Ferroptosis, Hepatocytes. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Anhui Medical University, Science Fund for Distinguished Young Scholars of Anhui Province, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Liver transplantation, the only curative option for end-stage liver disease, is limited by ischemia-reperfusion injury, with hepatocyte ferroptosis as a key pathogenic mechanism. CD36, a fatty acid translocase, drives the progression of multiple liver diseases. Yet, its role in hepatic ischemia-reperfusion injury (HIRI) and ferroptosis remains unclear. In this study, we generated full and hepatocyte-specific CD36 knockout mice to investigate its impact on HIRI. A significant upregulation of CD36 was observed in livers following ischemia-reperfusion (I/R) injury and in primary hepatocytes after hypoxia-reoxygenation (H/R). CD36 knockout alleviated liver injury and ferroptosis in HIRI models. In vitro, CD36 silencing suppressed H/R induced ferroptosis. Furthermore, our results establish rutin, a flavonoid derived from Gardenia, as a novel inhibitor of hepatocyte CD36 that alleviates HIRI. Mechanistically, CD36 regulates fatty acid binding protein 5 (FABP5) to reprogram lipid metabolism and drive ferroptosis in HIRI. Additionally, Rutin suppresses CD36 transcription through the stabilization of hepatocyte nuclear factor 4 α (HNF4α). Our findings demonstrate that CD36 exacerbates HIRI by regulating FABP5-mediated lipid metabolism and ferroptosis, while rutin exerts protective effects via CD36 inhibition. These results highlight the therapeutic potential of rutin for HIRI and identify the CD36/FABP5 axis as a novel target for intervention.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CD36 AntigensReperfusion InjuryFerroptosisHepatocytesRutinLiverLiver DiseasesAnimalsMice, KnockoutMiceMaleMice, Inbred C57BLHumansLipid MetabolismCells, Cultured

Stichwörter der Autor:innen

CD36FABP5FerroptosisHNF4αHepatic ischemia-reperfusion injuryRutin

Substanzen

CD36 AntigensRutinCd36 protein, mouse

Autor:innen und Institutionen

  • Inflammation and Immune Mediated Diseases Laboratory of Anhui Province, Anhui Institute of Innovative Drugs, School of Pharmacy, Anhui Medical University, Hefei 230032, Anhui, China.
  • The First Affiliated Hospital of Anhui Medical University, Hefei, China.
  • Inflammation and Immune Mediated Diseases Laboratory of Anhui Province, Anhui Institute of Innovative Drugs, School of Pharmacy, Anhui Medical University, Hefei 230032, Anhui, China. Electronic address: huangcheng@ahmu.…
  • Inflammation and Immune Mediated Diseases Laboratory of Anhui Province, Anhui Institute of Innovative Drugs, School of Pharmacy, Anhui Medical University, Hefei 230032, Anhui, China. Electronic address: mataotao@ahmu.ed…
  • Inflammation and Immune Mediated Diseases Laboratory of Anhui Province, Anhui Institute of Innovative Drugs, School of Pharmacy, Anhui Medical University, Hefei 230032, Anhui, China. Electronic address: lj@ahmu.edu.cn.

Förderung

  • Anhui Medical University
  • Science Fund for Distinguished Young Scholars of Anhui Province
  • National Natural Science Foundation of China

Zitieren

APA

Liu, Z., Wang, M., Li, L., Zhang, W., Meng, W., Cao, C., Song, H., Fang, X., Zhu, Y., Yang, M., Du, C., Zhang, Y., Huang, C., Ma, T., & Li, J. (2026). Rutin ameliorates hepatic ischemia-reperfusion injury by targeting CD36 to suppress hepatocyte ferroptosis. International Immunopharmacology, 172, 116231. https://doi.org/10.1016/j.intimp.2026.116231

Vancouver

Liu Z, Wang M, Li L, Zhang W, Meng W, Cao C, et al. Rutin ameliorates hepatic ischemia-reperfusion injury by targeting CD36 to suppress hepatocyte ferroptosis. International Immunopharmacology. 2026;172:116231. doi:10.1016/j.intimp.2026.116231

BibTeX
@article{Liu2026,
  author = {Liu, Zhenlong and Wang, Miaomiao and Li, Liangyun and Zhang, Wenmei and Meng, Wenna and Cao, Chengjiang and Song, Hehang and Fang, Xue and Zhu, Yan and Yang, Ming and Du, Changlin and Zhang, Yuan and Huang, Cheng and Ma, Taotao and Li, Jun},
  title = {Rutin ameliorates hepatic ischemia-reperfusion injury by targeting CD36 to suppress hepatocyte ferroptosis},
  journal = {International Immunopharmacology},
  year = {2026},
  volume = {172},
  pages = {116231},
  doi = {10.1016/j.intimp.2026.116231}
}
Kostenlos starten →